Tamil Nadu's Directorate of Drugs Control has stepped up surveillance of medicine pricing and prescription drug sales following reports that some hospitals may be charging inpatients at or close to the maximum retail price (MRP) for medicines and medical supplies purchased from manufacturers or distributors at discounted rates. The state drug control authority has ordered inspections at selected hospitals and their attached pharmacies to examine whether patients are being billed appropriately. The move comes amid broader public health concerns over the pricing of medicines and the need to ensure transparency in the way hospitals procure and sell drugs, devices and consumables to patients.

The inspections will focus on medicines as well as medical devices and other consumable healthcare products supplied to inpatients. Drug control officials are expected to examine procurement records, purchase invoices and other documentation to determine the prices paid by hospitals and compare them with the amounts subsequently charged to patients. Patient bills will also be scrutinised as part of the exercise. The objective is to identify cases where hospitals may have purchased products at substantially lower rates but billed patients at or near the MRP without adequate justification. Officials will also examine whether the products being sold comply with applicable pricing, packaging and labelling requirements.

The MRP printed on a medicine or medical product represents the maximum price at which it can ordinarily be sold to a consumer, including applicable taxes. However, concerns can arise when hospitals procure medicines and supplies through institutional channels at negotiated or discounted rates and subsequently pass on charges to patients at significantly higher prices. Such practices can increase the financial burden on patients, particularly those undergoing prolonged hospitalisation or treatment involving expensive medicines and medical consumables. The inspections are therefore expected to focus not only on the price displayed on the product but also on the procurement trail and the manner in which the final amount has been calculated and reflected on patient bills.

Also Read: Tamil Nadu CM Vijay At 52, His Reported Workout Routine And Fitness Habits

The Directorate of Drugs Control will also examine prescription drug sales as part of the wider surveillance effort. Inspectors may check whether pharmacies attached to hospitals are maintaining the required records and following rules governing the sale and dispensing of medicines that require a prescription. The exercise is intended to ensure that prescription medicines are supplied through appropriate channels and that pharmacies comply with applicable drug control requirements. Proper documentation of purchases and sales is particularly important for medicines subject to tighter regulatory oversight, as records can help authorities trace products through the supply chain and investigate potential violations.

The inspection process could also help identify discrepancies between hospital procurement records and patient billing practices. Officials can compare supplier invoices with stock registers, dispensing records and individual patient bills to establish how a medicine or consumable moved through the system and at what price it was ultimately charged. Any suspected violations of drug pricing, labelling or sale requirements can then be examined under the applicable regulatory framework. The scrutiny of medical devices and consumables is significant because hospital bills often contain a wide range of products beyond conventional medicines, including items used during procedures and inpatient care. A comprehensive review can therefore provide a clearer picture of how healthcare products are priced and billed.

The Tamil Nadu action highlights the importance of transparency in medicine pricing, particularly as patients and families face rising healthcare expenses. Hospitals and pharmacies are expected to maintain proper procurement and sales records and comply with the regulatory requirements governing medicines and other healthcare products. By comparing the prices paid during procurement with the amounts charged to patients, drug control officials can identify potential irregularities and determine whether further action is warranted. The inspections are also expected to reinforce compliance among hospitals and pharmacies while providing greater scrutiny of prescription drug sales. The Directorate's decision to examine selected institutions signals increased regulatory attention to the pricing and distribution of medicines, medical devices and consumables in the state's healthcare system.

Also Read: Tamil Nadu Hospitals Expand Fever Treatment Facilities As Dengue Cases Rise